Informa (INF) Receives Add Rating from Peel Hunt
Peel Hunt reissued their add rating on shares of Informa (LON:INF) in a research note published on Tuesday, ThisIsMoney.Co.Uk reports.
Several other equities research analysts have also recently issued reports on the stock. Shore Capital reissued a top pick rating on shares of Informa in a research report on Thursday, January 3rd. Goldman Sachs Group reissued a buy rating and issued a GBX 849 ($11.09) price objective (down from GBX 991 ($12.95)) on shares of Informa in a research report on Monday, January 14th. Societe Generale reissued a buy rating and issued a GBX 960 ($12.54) price objective on shares of Informa in a research report on Friday, January 25th. Barclays reduced their price target on shares of Informa from GBX 855 ($11.17) to GBX 785 ($10.26) and set an overweight rating for the company in a report on Friday, February 8th. Finally, Liberum Capital restated a buy rating on shares of Informa in a report on Thursday, March 7th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock presently has an average rating of Buy and an average price target of GBX 862.50 ($11.27).
Informa stock opened at GBX 803.20 ($10.50) on Tuesday. The stock has a market capitalization of $10.08 billion and a price-to-earnings ratio of 40.77. The company has a debt-to-equity ratio of 46.65, a current ratio of 0.47 and a quick ratio of 0.38. Informa has a 1 year low of GBX 602.80 ($7.88) and a 1 year high of GBX 869.60 ($11.36).
Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.
Featured Article: What is a recession?
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.